Lymphocyte-specific genomic instability and risk of lymphoid malignancy

Seminars in Immunology

Volumn 9, Issue 3, 1997, Pages 207-215

  Kirsch, Ilan R ^a   Lista, Florigio ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Ataxia telangectasia; Lymphoma; SCID; Trans rearrangements; V(D)J recombination

Indexed keywords

ARTICLE; ENVIRONMENTAL FACTOR; GENETIC STABILITY; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; LYMPHATIC SYSTEM TUMOR; LYMPHOMA;

EID: 0031170828     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1997.0071     Document Type: Article

References (96)

1. 1. Lewis SM (1994) The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses. Adv Immunol 56:27-150
2. 2. Schatz DG, Oettinger MA, Baltimore D (1989) The V(D)J recombination activating gene, RAG-1. Cell 59:1035-1048
3. 3. Oettinger MA, Schatz DG, Gorka C, Baltimore D (1990) RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517-1523
4. 4. Jackson SP, Jeggo PA (1995) DNA double-strand break repair and V(D)J recombination: involvement of DNA-PK. Trends Biochem Sci 20:412-415
5. 5. Blunt T, Finnie NJ, Taccioli GE, Smith GC, Demengeot J, Gottlieb TM, Mizuta R, Varghese AJ, Alt FW, Jeggo PA, et al (1995) Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80:813-823
6. 6. Kirchgessner CU, Patil CK, Evans JW, Cuomo CA, Fried LM, Carter T, Oettinger MA, Brown JM (1995) DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267:1178-1183
7. 7. Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D (1993) Mice lacking TdT: mature animals with an immature lymphocyte repertoire 'published erratum appears in Science 1993; 262: 1957] Science 261:1175-1178
8. 8. Komori T, Okada A, Stewart V, Alt FW (1993) Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes [published erratum appears in Science 1993: 1957], Science 261:1171-1175
9. 9. Yancopoulos GD, Alt FW (1985) Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40:271-281
10. 10. Blackwell TK, Moore MW, Yancopoulos GD, Suh H, Lutzker S, Selsing E, Alt FW (1986) Recombination between immunoglobulin variable region gene segments is enhanced by transcription. Nature 324:585-589
11. 11. Blackwell TK, Alt FW (1989) Mechanism and developmental program of immunoglobulin gene rearrangement in mammals. Annu Rev Genet 23:605-636
12. 12. Oltz EM, Alt FW, Lin WC, Chen J, Taccioli G, Desiderio S, Rathbun G (1993) A V(D)J recombinase-inducible B-cell line: role of transcriptional enhancer elements in directing V(D)J recombination. Mol Cell Biol 13: 6223-6230
13. 13. Baer R, Chen KC, Smith SD, Rabbitts TH (1985) Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors. Cell 43:705-713
14. 14. Denny CT, Yoshikai Y, Mak TW, Smith SD, Hollis GF, Kirsch IR (1986) A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci. Nature 320:549-551
15. 15. Denny CT, Hollis GF, Hecht F, Morgan R, Link MP, Smith SD, Kirsch IR (1986) Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development. Science 234:197-200
16. 16. Stern MH, Lipkowitz S, Aurias A, Griscelli C, Thomas G, Kirsch IR (1989) Inversion of chromosome 7 in ataxia telangiectasia is generated by a rearrangement between T-cell receptor beta and T-cell receptor gamma genes. Blood 74:2076-2080
17. 17. Tycko B, Palmer JD, Sklar J (1989) T cell receptor gene trans-rearrangements: chimeric gamma-delta genes in normal lymphoid tissues. Science 245:1242-1246
18. 18. Lipkowitz S, Stern MH, Kirsch IR (1990) Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasis lymphocytes. J Exp Med 172:409-418
19. 19. Kobayashi Y, Tycko B, Soreng AL, Sklar J (1991) Trans-rearrangement between antigen receptor genes in normal human lymphoid tissues and in ataxia telangiectasia. J Immunol 147:3201-3209
20. 20. Mallick CA, Dudley EC, Viney JL, Owen MJ, Hayday AC (1993) Rearrangement and diversity of T cell receptor beta chain genes in thymocytes: a critical role for the beta chain in development. Cell 73:513-519
21. 21. Dudley EC, Petrie HT, Shah LM, Owen MJ, Hayday AC (1994) T cell receptor beta chain gene rearrangement and selection during thymocyte development in adult mice. Immunity 1:83-93
22. 22. Gross G, Waks T, Eshhar Z (1989) Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci USA 86:10024-10028
23. 23. Becker ML, Near R, Mudgett-Hunter M, Margolies MN, Kubo RT, Kaye J, Hedrick SM (1989) Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice. Cell 58:911-921
24. 24. Davodeau F, Peyrat MA, Gaschet J, Hallet MM, Triebel F, Vie H, Kabelitz D, Bonneville M (1994) Surface expression of functional T cell receptor chains formed by interlocus recombination on human T lymphocytes. J Exp Med 180:1685-1691
25. 25. Aurias A, Dutrillaux B, Buriot D, Lejeune J (1980) High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia telangiectasia. Mutat Res 69:369-374
26. 26. Aurias A, Couturier J, Dutrillaux AM, Dutrillaux B, Herpin F, Lamoliatte E, Lombard M, Muleris M, Paravatou M, Prieur M, et al (1985) Inversion (14)(q12qter) or (q11.2q32.3): the most frequently acquired rearrangement in lymphocytes. Hum Genet 71:19-21
27. 27. Aurias A (1993) Acquired chromosomal aberrations in normal individuals, in The Causes and Consequences of Chromosomal Aberrations, (Kirsch, IR, ed.) p 125. CRC Press, Inc., Boca Raton, Florida
28. 28. Welch JP, Lee CL, Beatty-DeSana JW, Hoggard MJ, Cooledge JW, Hecht F, McCawBK, Peakman D, Robinson A (1975) Non-random occurrence of 7-14 translocations in human lymphocyte cultures. Nature 255:241-245
29. 29. Zech L, Haglund U (1978) A recurrent structural aberration, t(7;14), in phytohemagglutinin-stimulated lymphocytes. Hereditas 89:69-73
30. 30. Mattel MG, Ayme S, Mattel JF, Aurran Y, Giraud F (1979) Distribution of spontaneous chromosome breaks in man. Cytogenet Cell Genet 23:95-102
31. 31. Herva R (1981) Inv(7) as a recurrent aberration in human lymphocyte cultures. Hereditas 95:163-164
32. 32. Hecht F, Hecht BK, Kirsch IR (1987) Fragile sites limited to lymphocytes: molecular recombination and malignancy. Cancer Genet Cytogenet 26:95-104
33. 33. Boder E (1985) Ataxia-telangiectasia: an overview, in Ataxia-Telangiectasia: Genetics, Neuropathology, and Immunology of a Degenerative Disease of Childhood, (Gatti RA, Swift M, eds). Alan R. Liss, New York, 1985
34. 34. Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia [see comments]. N Engl J Med 325:1831-1836
35. 35. Swift M (1994) Ionizing radiation, breast cancer, and ataxia-telangiectasia [editorial; comment]. J Natl Cancer Inst 86:1571-1572
36. 36. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, et al (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase [see comments]. Science 268:1749-1753
37. 37. Zakian VA (1995) ATM-elated genes: what do they tell us about functions of the human gene? Cell 82:685-687
38. 38. Gatti RA, Good RA (1971) Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 28:89-98
39. 39. Butterworth SV, Taylor AM (1986) A subpopulation of t(2;14)(p11;q32) cells in ataxia telangiectasia B lymphocytes. Hum Genet 73:346-349
40. 40. Stern MH (1993) Clonal proliferations in AT, in The Causes and Consequences of Chromosomal Aberrations, (Kirsch IR, ed.) pp.165-176. CRC Press, Inc., Boca Raton, Florida
41. 41. McCaw BK, Hecht F, Harnden DG, Teplitz RL (1975) Somatic rearrangement of chromosome 14 in human lymphocytes. Proc Natl Acad Sci USA 72:2071-2075
42. 42. Levitt R, Pierre RV, White WL, Siekert RG (1978) Atypical lymphoid leukemia in ataxia telangiectasia. Blood 52:1003-1011
43. 43. Saxon A, Stevens RH, Golde DW (1979) Helper and suppressor t-lymphocyte leukemia in ataxia telangiectasia. N Engl J Med 300:700-704
44. 44. Sparkes RS, Como R, Golde DW (1980) Cytogenetic abnormalities in ataxia telangiectasia with T cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 1:329
45. 45. Taylor AM, Butterworth SV (1986) Clonal evolution of T-cell chronic lymphocytic leukaemia in a patient with ataxia telangiectasia. Int J Cancer 37:511-516
46. 46. Taylor AM, Lowe PA, Stacey M, Thick J, Campbell L, Beatty D, Biggs P, Formstone CJ (1992) Development of T-cell leukaemia in an ataxia telangiectasia patient following clonal selection in t(X;14)-containing lymphocytes. Leukemia 6:961-966
47. 47. Baer R, Heppell A, Taylor AM, Rabbitts PH, Boullier B, Rabbitts TH (1987) The breakpoint of an inversion of chromosome 14 in a T-cell leukemia: sequences downstream of the immunoglobulin heavy chain locus are implicated in tumorigenesis. Proc Natl Acad Sci USA 84:9069-9073
48. 48. Bertness VL, Felix CA, McBride OW, Morgan R, Smith SD, Sandberg AA, Kirsch IR (1990) Characterization of the breakpoint of a t(14;14)(q11.2;q32) from the leukemic cells of a patient with T-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet 44:47-54
49. 49. Davey MP, Bertness V, Nakahara K, Johnson JP, McBride OW, Waldmann TA, Kirsch IR (1988) Juxtaposition of the T-cell receptor alpha-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia. Proc Natl Acad Sci USA 85:9287-9291
50. 50. Mengle-Gaw L, Willard HF, Smith CI, Hammarstrom L, Fischer P, Sherrington P, Lucas G, Thompson PW, Baer R, Rabbitts TH, Mengle-Gaw L, Albertson DG, Sherrington PD, Rabbitts TH (1987) Human T-cell tumours containing chromosome 14 inversion or translocation with breakpoints proximal to immunoglobulin joining regions at 14q32. Analysis of a T-cell tumor-specific breakpoint cluster at human chromosome 14q32. Embo J 6:2273-2280
51. 51. Mengle-Gaw L, Albertson DG, Sherrington PD, Rabbitts TH (1988) Analysis of a T-cell tumor-specific breakpoint cluster at human chromosome 14q32. Proc Natl Acad Sci USA 85:9171-9175
52. 52. Russo G, Isobe M, Pegoraro L, Finan J, Nowell PC, Croce CM (1988) Molecular analysis of a t(7;14)(q35;q32) chromosome translocation in a T cell leukemia of a patient with ataxia telangiectasia. Cell 53:137-144
53. 53. Fisch P, Forster A, Sherrington PD, Dyer MJ, Rabbitts TH (1993) The chromosomal translocation t(x;14)(q28;q11) in T-cell pro-lymphocytic leukaemia breaks within one gene and activates another. Oncogene 8:3271-3276
54. 54. Stern MH, Soulier J, Rosenzwajg M, Nakahara K, Canki-Klain N, Aurias A, Sigaux F, Kirsch IR (1993) MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. Oncogene 8:2475-2483
55. 55. Thick J, Mak YF, Metcalfe J, Beatty D, Taylor AM (1994) A gene on chromosome Xq28 associated with T-cell prolymphocytic leukemia in two patients with ataxia telangiectasia. Leukemia 8:564-573
56. 56. Hsieh CL, Arlett CF, Lieber MR (1993) V(D)J recombination in ataxia telangiectasia, Bloom's syndrome, and a DNA ligase I-associated immunodeficiency disorder. J Biol Chem 268:20105-20109
57. 57. Pandita TK, Hittelman WN (1994) Increased initial levels of chromosome damage and heterogeneous chromosome repair in ataxia telangiectasia heterozygote cells. Mutat Res 310:1-13
58. 58. Liu N, Bryant PE (1993) Response of ataxia telangiectasia cells to restriction endonuclease induced DNA double-strand breaks: I. Cytogenetic characterization. Mutagenesis 8:503-510
59. 59. Meyn MS (1993) High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia. Science 260:1327-1330
60. 60. Blair A, Malker H, Cantor KP, Burmeister L, Wiklund K (1985) Cancer among farmers. A review. Scand J Work Environ Health 11:397-407
61. 61. Hoar SK, Blair A, Holmes FF, Boysen CD, Robel RJ, Hoover R, Fraumeni JF Jr (1986) Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma [published erratum appears in JAMA 1986; 256:3351]. JAMA 256:1141-1147
62. 62. Alavanja MC, Blair A, Merkle S, Teske J, Eaton B, Reed B (1989) Mortality among forest and soil conservationists. Arch Environ Health 44:94-101
63. 63. Weisenburger DD (1994) Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic. Ann Oncol 5 Suppl 1:19-24
64. 64. Lipkowitz S, Carry VF, Kirsch IR (1992) Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies. Proc Natl Acad Sci USA 89:5301-5305
65. 65. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg S (1988) Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76-81
66. 66. van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R (1994) Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 12:312-325
67. 67. Abdallah JM, Lombardi DP, Kirsch IR (1995) Genetic instability in patients with Hodgkin's disease undergoing chemotherapy. J Clin Invest 96:2744-2747
68. 68. Caggana M, Liber HL, Mauch PM, Coleman CN, Kelsey KT (1991) In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients. Environ Mol Mutagen 18:6-13
69. 69. Mott MG, Boyse J, Hewitt M, Radford M (1994) Do mutations at the glycophorin A locus in patients treated for childhood Hodgkin's disease predict secondary leukaemia? [see comments]. Lancet 343:828-829
70. 70. Kaplan HS, Brown MB (1952) A quantitative dose-response study of lymphoid-tumor development in irradiated C57 black mice. J Natl Cancer Inst 13:185
71. 71. Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530
72. 72. Bosma MJ, Carroll AM (1991) The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol 9:323-350
73. 73. Rothenberg EV, Chen D, Diamond R (1993) Functional and phenotypic analysis of thymocytes in SCID mice. Evidence for functional response transitions before and after the SCID arrest point. J Immunol 151:3530-3546
74. 74. Schuler W, Weiler IJ, Schuler A, Phillips RA, Rosenberg N, Mak TW, Kearney JF, Perry RP, Bosma MJ (1986) Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 46:963-972
75. 75. Kim MG, Schuler W, Bosma MJ, Marcu KB (1988) Abnormal recombination of Igh D and J gene segments in transformed pre-B cells of scid mice. J Immunol 141:1341-1347
76. 76. Okazaki K, Nishikawa S, Sakano H (1988) Aberrant immunoglobulin gene rearrangement in scid mouse bone marrow cells. J Immunol 141:1348-1352
77. 77. Lieber MR, Hesse JE, Lewis S, Bosma GC, Rosenberg N, Mizuuchi K, Bosma MJ, Gellert M (1988) The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell 55:7-16
78. 78. Malynn BA, Blackwell TK, Fulop GM, Rathbun GA, Furley AJ, Ferrier P, Heinke LB, Phillips RA, Yancopoulos GD, Alt FW (1988) The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 54:453-460
79. 79. Roth DB, Menetski JP, Nakajima PB, Bosma MJ, Gellert M (1992) V(D)J recombination: broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes. Cell 70:983-991
80. 80. Roth DB, Nakajima PB, Menetski JP, Bosma MJ, Gellert M (1992) V(D)J recombination in mouse thymocytes: double-strand breaks near T cell receptor delta rearrangement signals. Cell 69:41-53
81. 81. Lieber MR (1993) Site-specific recombination in the immune system. FASEB 5:2934-2944
82. 82. Carroll AM, Bosma MJ (1991) T-lymphocyte development in scid mice is arrested shortly after the initiation of T-cell receptor delta gene recombination. Genes Dev 5:1357-1366
83. 83. Carroll AM, Slack JK, Chang WT (1993) Biased T-cell receptor delta element recombination in scid thymocytes. Mol Cell Biol 13:3632-3640
84. 84. Fulop GM, Phillips RA (1990) The scid mutation in mice causes a general defect in DNA repair. Nature 347:479-482
85. 85. Miller RD, Hogg J, Ozaki JH, Gell D, Jackson SP, Riblet R (1995) Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proc Natl Acad Sci USA 92:10792-10795
86. 86. Boubnov NV, Weaver DT (1995) scid cells are deficient in Ku and replication protein A phosphorylation by the DNA-dependent protein kinase. Mol Cell Biol 15:5700-5706
87. 87. Danska JS, Pflumio F, Williams CJ, Huner O, Dick JE, Guidos CJ (1994) Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science 266:450-455
88. 88. Lista F, Bertness V, Guidos CJ, Danska JS, Kirsch IR (1997) The absolute number of trans-rearrangements between the TCRG and TCRB loci is predictive of lymphoma risk: a SCID murine model. In press
89. 89. Bogue MA, Zhu C, Auilar-Cordova E, Donehower LA, Roth DB (1996) p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev 10:553-565
90. 90. Livak F, Petrie HT, Crispe IN, Schatz DG (1995) In-frame TCR delta gene rearrangements play a critical role in the alpha beta/gamma delta T cell lineage decision. Immunity 2:617-627
91. 91. Nakajima PB, Menetski JP, Roth DB, Gellert M, Bosma MJ (1995) V-D-J rearrangements at the T cell receptor delta locus in mouse thymocytes of the alpha beta lineage. Immunity 3:609-621
92. 92. Hartley KO, Gell D, Smith GC, Zhang H, Divecha N, Connelly MA, Admon A, Lees-Miller SP, Anderson CW, Jackson SP (1995) DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82:849-856
93. 93. Hunter T (1995) When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83:14
94. 94. Tycko B, Sklar J (1990) Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells 2:1-8
95. 95. Lieber MR (1993) The role of site-directed recombinases in physiologic and pathologic chromosomal rearrangements, in The Causes and Consequences of Chromosomal Aberrations, (Kirsch IR, ed.) pp 239-275. CRC Press, Inc., Boca Raton, Florida
96. 96. Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372:143-149